Clinical Trials List
Protocol NumberTTYDC0301
Not yet recruiting
2004-03-01 - 2005-08-01
Phase II
Terminated3
-
Trial Applicant
TTY Biopharm Company Limited
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Co-Principal Investigator
- 馮盈勳 Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Tsai-Yun Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
47 participants
-
Global
47 participants
